EODData

FRA, 2M7C: China Medical System Holdings Limited

22 Dec 2025
LAST:

1.420

CHANGE:
 0.02
OPEN:
1.410
HIGH:
1.420
ASK:
0.000
VOLUME:
757
CHG(%):
1.39
PREV:
1.440
LOW:
1.410
BID:
0.000
 

CHART

RECENT END OF DAY PRICES

DateOpenHighLowCloseVolume
22 Dec 251.4101.4201.4101.420757
19 Dec 251.4201.4801.4201.440757
18 Dec 251.4301.4501.4301.45046
17 Dec 251.4401.4401.4201.42046
16 Dec 251.4201.4301.4201.43046
15 Dec 251.4701.4701.4101.41046
12 Dec 251.4201.4401.4201.430544
10 Dec 251.4701.5201.4701.480544
09 Dec 251.5101.5201.5101.510500
08 Dec 251.4801.5401.4801.480544

PROFILE

Name:China Medical System Holdings Limited
About:China Medical System Holdings Limited, an investment holding company, manufactures, sells, markets, and promotes pharmaceutical products in the People's Republic of China. The company offers cardio-cerebrovascular products include VELPHORO, a sucroferric oxyhydroxide chewable tablets and diazepam nasal spray for seizure clusters; XinHuoSu, a recombinant human brain natriuretic peptide for acute heart failure; Plendil, a felodipine sustained release tablets for hypertension; and Deanxit, a flupentixol and melitracen tablets for mild-to-moderate depression. It also provides gastroenterology products, such as METOJECT, a methotrexate injection to treat severe recalcitrant disabling psoriasis and rheumatoid arthritis; LUMEBLUE, a methylthioninium chloride enteric-coated sustained-release tablets for colorectal lesion visualization; Salofalk for ulcerative colitis and Crohn's disease; Bioflor, a saccharomyces boulardii sachets for diarrhea; Combizym and Cidine for digestive enzymes; and Ursofalk, a ursodeoxycholic acid capsules to treat cholesterol gallstones. In addition, the company offers dermatology products, including ILUMETRI, a tildrakizumab injection for the treatment of plaque psoriasis; Aethoxysklerol, a polidocanol injection for sclerotherapy of various varicose veins; Hirudoid, a mucopolysaccharide polysulfate cream to treat blunt traumata; skin heling soothing product; and Hirudoid for acne-prone skin care, prevention, and enhancement of acne. Further, it provides Vmonalisa, modified sodium hyaluronate filler for mid to deep dermal implantation; augentropfen stulln mono eye drops for asthenopia; EyeOP1 glaucoma treatment device; and Elcitonin for Osteoporosis pain. The company was founded in 1995 and is headquartered in North Point, Hong Kong. China Medical System Holdings Limited is a subsidiary of Treasure Sea Limited.
Sector:Healthcare
Address:Island Place Tower, North Point, Hong Kong
Website:https://web.cms.net.cn/zh/home/
ISIN:KYG211081248
LEI:529900Z57DVJXUBLHX66

API SERVICE  NEW

Have you tried our new API Service yet?

For more information, visit our API page.

You can get your ApiKey over HERE.

If you're ready to get going, then jump over to:
https://api.eoddata.com

SYMBOL HISTORY

   Add to Watchlist

DOWNLOAD DATA

Download stock quote history quickly and easily in a variety of formats to suit your needs.

FUNDAMENTALS

Trailing P/E:19.00 
Forward P/E:8.08 
Price to Sales:0.48 
Price to Book:0.22 
Profit Margin:0.21 
Operating Margin:0.21 
Return on Assets:0.06 
Return on Equity:0.10 
DivYield:0.19 
Div/Share:0.27 
Revenue:957.73M 
EBITDA:292.45M 
Shares:2.44B 
Market Cap:3.464B 

TECHNICAL INDICATORS

MA5:1.430.8%
MA10:1.451.9%
MA20:1.452.2%
MA50:1.473.6%
MA100:1.484.0%
MA200:1.2711.9%
STO9:9.09 
STO14:7.69 
RSI14:38.71 
WPR14:-90.00 
MTM14:-0.07
ROC14:-0.05 
ATR:0.05 
Week High:1.484.2%
Week Low:1.410.7%
Month High:1.548.5%
Month Low:1.4111.9%
Year High:1.6516.2%
Year Low:0.8077.7%
Volatility:16.00 

RECENT SPLITS

Date Ratio
27 Apr 20123-2

RECENT DIVIDENDS

Date Amount
29 Aug 2025$0.02
28 Apr 2025$0.01
29 Aug 2024$0.02
13 May 2024$0.01
11 Sep 2023$0.04
03 May 2023$0.03
05 Sep 2022$0.04
26 Apr 2022$0.03
06 Sep 2021$0.04
29 Apr 2021$0.03